Global Oral Testosterone Market Growth 2025-2031

Publication ID:

LPI05254458

Publication Date:

May 13, 2025

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Oral Testosterone market size is predicted to grow from US$ 136 million in 2025 to US$ 162 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.
Oral Testosterone refers to testosterone that is taken in the form of a pill, capsule, or tablet to be ingested. Testosterone is the primary male sex hormone, and it plays a vital role in various bodily functions, including the development of male sexual characteristics, muscle growth, bone density, and the regulation of mood and energy levels. Oral testosterone is typically used for testosterone replacement therapy (TRT) in men who have low testosterone levels (a condition known as hypogonadism).
United States market for Oral Testosterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oral Testosterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oral Testosterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oral Testosterone players cover Organon, Bayer, Clarus Therapeutics, Marius Pharmaceuticals, Zhejiang Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淥ral Testosterone Industry Forecast鈥� looks at past sales and reviews total world Oral Testosterone sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Testosterone sales for 2025 through 2031. With Oral Testosterone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Testosterone industry.
This Insight Report provides a comprehensive analysis of the global Oral Testosterone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Testosterone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oral Testosterone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Testosterone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Testosterone.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Testosterone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Capsules
Tablets
Segmentation by Application:
Medical
Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Organon
Bayer
Clarus Therapeutics
Marius Pharmaceuticals
Zhejiang Medicine
Tianjin Lisheng Pharmaceutical
Sunpharma
Antares Pharma
Power Health
Ardana
Endo Pharmaceuticals
Mylan
Novo Nordisk
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Testosterone market?
What factors are driving Oral Testosterone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Testosterone market opportunities vary by end market size?
How does Oral Testosterone break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Testosterone Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Testosterone by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Testosterone by Country/Region, 2020, 2024 & 2031
2.2 Oral Testosterone Segment by Type
2.2.1 Capsules
2.2.2 Tablets
2.3 Oral Testosterone Sales by Type
2.3.1 Global Oral Testosterone Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Testosterone Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Testosterone Sale Price by Type (2020-2025)
2.4 Oral Testosterone Segment by Application
2.4.1 Medical
2.4.2 Research
2.5 Oral Testosterone Sales by Application
2.5.1 Global Oral Testosterone Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Testosterone Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Testosterone Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Oral Testosterone Breakdown Data by Company
3.1.1 Global Oral Testosterone Annual Sales by Company (2020-2025)
3.1.2 Global Oral Testosterone Sales Market Share by Company (2020-2025)
3.2 Global Oral Testosterone Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Testosterone Revenue by Company (2020-2025)
3.2.2 Global Oral Testosterone Revenue Market Share by Company (2020-2025)
3.3 Global Oral Testosterone Sale Price by Company
3.4 Key Manufacturers Oral Testosterone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Testosterone Product Location Distribution
3.4.2 Players Oral Testosterone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oral Testosterone by Geographic Region
4.1 World Historic Oral Testosterone Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Testosterone Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Testosterone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Testosterone Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Testosterone Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Testosterone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Testosterone Sales Growth
4.4 APAC Oral Testosterone Sales Growth
4.5 Europe Oral Testosterone Sales Growth
4.6 Middle East & Africa Oral Testosterone Sales Growth
5 Americas
5.1 Americas Oral Testosterone Sales by Country
5.1.1 Americas Oral Testosterone Sales by Country (2020-2025)
5.1.2 Americas Oral Testosterone Revenue by Country (2020-2025)
5.2 Americas Oral Testosterone Sales by Type (2020-2025)
5.3 Americas Oral Testosterone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Testosterone Sales by Region
6.1.1 APAC Oral Testosterone Sales by Region (2020-2025)
6.1.2 APAC Oral Testosterone Revenue by Region (2020-2025)
6.2 APAC Oral Testosterone Sales by Type (2020-2025)
6.3 APAC Oral Testosterone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Testosterone by Country
7.1.1 Europe Oral Testosterone Sales by Country (2020-2025)
7.1.2 Europe Oral Testosterone Revenue by Country (2020-2025)
7.2 Europe Oral Testosterone Sales by Type (2020-2025)
7.3 Europe Oral Testosterone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Testosterone by Country
8.1.1 Middle East & Africa Oral Testosterone Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Testosterone Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Testosterone Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Testosterone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Testosterone
10.3 Manufacturing Process Analysis of Oral Testosterone
10.4 Industry Chain Structure of Oral Testosterone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Testosterone Distributors
11.3 Oral Testosterone Customer
12 World Forecast Review for Oral Testosterone by Geographic Region
12.1 Global Oral Testosterone Market Size Forecast by Region
12.1.1 Global Oral Testosterone Forecast by Region (2026-2031)
12.1.2 Global Oral Testosterone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Testosterone Forecast by Type (2026-2031)
12.7 Global Oral Testosterone Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Organon
13.1.1 Organon Company Information
13.1.2 Organon Oral Testosterone Product Portfolios and Specifications
13.1.3 Organon Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Organon Main Business Overview
13.1.5 Organon Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Oral Testosterone Product Portfolios and Specifications
13.2.3 Bayer Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Clarus Therapeutics
13.3.1 Clarus Therapeutics Company Information
13.3.2 Clarus Therapeutics Oral Testosterone Product Portfolios and Specifications
13.3.3 Clarus Therapeutics Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Clarus Therapeutics Main Business Overview
13.3.5 Clarus Therapeutics Latest Developments
13.4 Marius Pharmaceuticals
13.4.1 Marius Pharmaceuticals Company Information
13.4.2 Marius Pharmaceuticals Oral Testosterone Product Portfolios and Specifications
13.4.3 Marius Pharmaceuticals Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Marius Pharmaceuticals Main Business Overview
13.4.5 Marius Pharmaceuticals Latest Developments
13.5 Zhejiang Medicine
13.5.1 Zhejiang Medicine Company Information
13.5.2 Zhejiang Medicine Oral Testosterone Product Portfolios and Specifications
13.5.3 Zhejiang Medicine Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Zhejiang Medicine Main Business Overview
13.5.5 Zhejiang Medicine Latest Developments
13.6 Tianjin Lisheng Pharmaceutical
13.6.1 Tianjin Lisheng Pharmaceutical Company Information
13.6.2 Tianjin Lisheng Pharmaceutical Oral Testosterone Product Portfolios and Specifications
13.6.3 Tianjin Lisheng Pharmaceutical Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Tianjin Lisheng Pharmaceutical Main Business Overview
13.6.5 Tianjin Lisheng Pharmaceutical Latest Developments
13.7 Sunpharma
13.7.1 Sunpharma Company Information
13.7.2 Sunpharma Oral Testosterone Product Portfolios and Specifications
13.7.3 Sunpharma Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sunpharma Main Business Overview
13.7.5 Sunpharma Latest Developments
13.8 Antares Pharma
13.8.1 Antares Pharma Company Information
13.8.2 Antares Pharma Oral Testosterone Product Portfolios and Specifications
13.8.3 Antares Pharma Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Antares Pharma Main Business Overview
13.8.5 Antares Pharma Latest Developments
13.9 Power Health
13.9.1 Power Health Company Information
13.9.2 Power Health Oral Testosterone Product Portfolios and Specifications
13.9.3 Power Health Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Power Health Main Business Overview
13.9.5 Power Health Latest Developments
13.10 Ardana
13.10.1 Ardana Company Information
13.10.2 Ardana Oral Testosterone Product Portfolios and Specifications
13.10.3 Ardana Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ardana Main Business Overview
13.10.5 Ardana Latest Developments
13.11 Endo Pharmaceuticals
13.11.1 Endo Pharmaceuticals Company Information
13.11.2 Endo Pharmaceuticals Oral Testosterone Product Portfolios and Specifications
13.11.3 Endo Pharmaceuticals Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Endo Pharmaceuticals Main Business Overview
13.11.5 Endo Pharmaceuticals Latest Developments
13.12 Mylan
13.12.1 Mylan Company Information
13.12.2 Mylan Oral Testosterone Product Portfolios and Specifications
13.12.3 Mylan Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Mylan Main Business Overview
13.12.5 Mylan Latest Developments
13.13 Novo Nordisk
13.13.1 Novo Nordisk Company Information
13.13.2 Novo Nordisk Oral Testosterone Product Portfolios and Specifications
13.13.3 Novo Nordisk Oral Testosterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Novo Nordisk Main Business Overview
13.13.5 Novo Nordisk Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂